Relx (LON:REL) Earns “Equal Weight” Rating from Barclays

Relx (LON:RELGet Free Report)‘s stock had its “equal weight” rating restated by stock analysts at Barclays in a research note issued on Friday, Marketbeat Ratings reports. They currently have a GBX 2,770 ($34.98) price objective on the stock. Barclays‘s price target points to a potential upside of 1.76% from the stock’s current price.

Separately, Investec raised Relx to a “buy” rating and set a GBX 2,850 ($35.99) target price for the company in a research note on Tuesday. Five analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of GBX 2,601.33 ($32.85).

Get Our Latest Stock Analysis on REL

Relx Stock Performance

LON REL traded up GBX 27 ($0.34) during trading hours on Friday, hitting GBX 2,722 ($34.38). 922,520 shares of the stock were exchanged, compared to its average volume of 2,973,159. The company has a quick ratio of 0.45, a current ratio of 0.47 and a debt-to-equity ratio of 209.30. The company has a market cap of £51.45 billion, a price-to-earnings ratio of 2,990.11, a price-to-earnings-growth ratio of 1.94 and a beta of 0.50. Relx has a 12-month low of GBX 2,124 ($26.82) and a 12-month high of GBX 2,735 ($34.54). The stock has a 50-day moving average of GBX 2,561.16 and a 200 day moving average of GBX 2,562.72.

Insider Activity at Relx

In other Relx news, insider Alistair R. Cox bought 950 shares of the business’s stock in a transaction on Tuesday, August 1st. The stock was bought at an average price of GBX 2,604 ($32.89) per share, for a total transaction of £24,738 ($31,242.74). 0.43% of the stock is owned by corporate insiders.

About Relx

(Get Free Report)

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.

See Also

Analyst Recommendations for Relx (LON:REL)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.